← Back to all trials
Not Yet Recruiting
NCT05657990
Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery
Conditions: Urinary Retention
Sex: Male
Ages: 55 Years – N/A
Phase: EARLY_PHASE1
Enrollment: 46
Sponsor: Hackensack Meridian Health
Location: United States
Summary
This is a feasibility study looking at whether the use of Tamsulosin could lower the high incidence of postoperative urinary retention (POUR) in older men who undergo an oncological thoracic surgical procedure for suspected or confirmed cancer.
In addition, the study will try to identify the time of resumption of presurgical urinary function post Tamsulosin administration.
Eligibility Criteria
Inclusion Criteria:Males≥55 years oldPlanned thoracic oncological surgical procedure of a video assisted oncological surgical procedure for suspected or confirmed cancer.Surgery scheduled more than 7 days from the time of consentExclusion Criteria:Using Tamsulosin alreadyKnown allergy to Tamsulosin or sulfa drugsCurrent use of BoceprevirResting systolic blood pressure <100Orthostatic hypotension of >20mm Hg systolic and/or 10mm Hg diastolic pressure from sitting to standing (after 2 minutes of standing) as measured at the time of consentKnown history of hypotensionKnown diagnosis of congestive heart failure (CHF) and valvular heart diseaseHistory of prior prostate surgery (prostatectomy, trans-urethral resection)
Source: ClinicalTrials.gov (NCT05657990). StuddyBuddy aggregates publicly available trial information.